Knowledge, attitudes, and practices towards prostate cancer screening amongst men living in the southern Italian peninsula: the Prevention and Research in Oncology (PRO) non-profit Foundation experience

Mirone, Vincenzo; Imbimbo, Ciro; Arcaniolo, Davide; Franco, Marco; Rocca, Roberto; Venturino, Luca; Spirito, Lorenzo; Creta, Massimiliano; Verze, Paolo
December 2017
World Journal of Urology;Dec2017, Vol. 35 Issue 12, p1857
Academic Journal
Purpose: We aimed to explore the knowledge, attitudes, and practices towards prostate cancer (PCa) risk factors and prevention amongst men living in the southern Italian peninsula. Methods: We retrospectively reviewed data collected during free preventive visits carried out by the Prevention and Research in Oncology (PRO) non-profit Foundation between July 2013 and July 2016. The following data were collected: demographic and clinical features, knowledge about PCa prevention and sources of knowledge, knowledge about PCa risk factors, previous prostate-specific antigen (PSA) test, previous digital rectal examination (DRE), previous prostate ultrasound, and general attitudes towards DRE. Results: The study population consisted of 2144 Caucasian men living in four regions in the south of Italy (Campania, Calabria, Molise, Puglia). Median age was 59 years. One thousand six hundred and ninety-nine (79.2%) subjects reported knowing the existence of PCa prevention programs. Most of them received information from the media while only 17.1% declared that the information on PCa prevention that they received was from their family physicians. One thousand two hundred seventy-five (59.5%) subjects declared knowing of the existence of PCa risk factors and 41.3% was aware of the existence of both genetic and exogenous factors. The percentage of subjects who reported having had at least one PSA test in their life was 77.8 and 55.4% reported having had a DRE. Conclusions: Knowledge about PCa screening amongst male subjects living in southern peninsular Italy is quite high. Knowledge of PCa risk factors is suboptimal and the practice of DRE is underutilized.


Related Articles

  • A urine-based methylation signature for risk stratification within low-risk prostate cancer. Jatkoe, T A; Karnes, R J; Freedland, S J; Wang, Y; Le, A; Baden, J // British Journal of Cancer;3/3/2015, Vol. 112 Issue 5, p802 

    Background:Prostate cancer overdiagnosis and overtreatment represents a major problem. Many men with low-grade disease on biopsy are undergraded and they harbour high-grade disease at prostatectomy with no reliable way to identify these men. We used a novel urine-based 2-gene methylation test to...

  • Characterization of SNPs Associated with Prostate Cancer in Men of Ashkenazic Descent from the Set of GWAS Identified SNPs: Impact of Cancer Family History and Cumulative SNP Risk Prediction. Agalliu, Ilir; Wang, Zhaoming; Wang, Tao; Dunn, Anne; Parikh, Hemang; Myers, Timothy; Burk, Robert D.; Amundadottir, Laufey // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Background: Genome-wide association studies (GWAS) have identified multiple SNPs associated with prostate cancer (PrCa). Population isolates may have different sets of risk alleles for PrCa constituting unique population and individual risk profiles. Methods: To test this hypothesis,...

  • HAVE YOU Read? Olsson, Carl A. // AUANews;Oct2012, p28 

    The author reviews articles on urology including "Prostate-Specific Antigen Screening for Prostate Cancer and the Risk of Overt Metastatic Disease at Presentation: Analysis of Trends Over Time" by E. Scosyrev and others in the July 30, 2012 "Cancer," "Radical Prostatectomy Versus Observation for...

  • Poor Glycemic Control of Diabetes Mellitus Is Associated with Higher Risk of Prostate Cancer Detection in a Biopsy Population. Park, Juhyun; Cho, Sung Yong; Lee, Young Ju; Lee, Seung Bae; Son, Hwancheol; Jeong, Hyeon // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Objectives: To evaluate the impact of glycemic control of diabetes mellitus (DM) on prostate cancer detection in a biopsy population. Patients and Methods: We retrospectively reviewed the records of 1,368 men who underwent prostate biopsy at our institution. We divided our biopsy population...

  • Zyflamend for prevention of prostate cancer: Studies show benefits, but larger trials needed. HUME, ANNE L. // Pharmacy Today;Jul2014, Vol. 20 Issue 7, p30 

    The article discusses the use of Zyflamend for prevention of prostate cancer, focusing on studies showing benefits and the need for larger trials. It mention a 2009 Phase 1 study on the safety and tolerability of Zyflamend with other supplements in 29 men with biopsy-proven high-grade prostatic...

  • Mitochondrial Cytochrome c Oxidase Subunit 1 Sequence Variation in Prostate Cancer. Scott, Takara A.; Arnold, Rebecca S.; Petros, John A. // Scientifica;2012, p1 

    Purpose. Mitochondrial DNA (mtDNA) mutations have been described in every adult neoplasm including prostate cancer. There are marked racial differences in mutations within the cytochrome c oxidase subunit 1 (COI) gene in individuals with prostate cancer (PCa). The purpose of this study was to...

  • Lack of association between XPC Lys939Gln polymorphism and prostate cancer risk: an updated meta-analysis based on 3039 cases and 3253 controls. Haoran Wu; Zhong Lv; Xugang Wang; Liang Zhang; Naixin Mo // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 10, p17959 

    Several studies have evaluated the relationship between xeroderma pigmentosum complementation group C (XPC) variants and prostate cancer (PCa) risk. However, the results remain inconclusive. The objective of this study was to identify the role of XPC Lys939Gln variant on PCa occurrence. Relevant...

  • Vitamin D, Sunlight and Prostate Cancer Risk. Donkena, Krishna Vanaja; Young, Charles Y. F. // Advances in Preventive Medicine;2011, Vol. 2011, p1 

    Prostate cancer is the second common cancer in men worldwide. The prevention of prostate cancer remains a challenge to researchers and clinicians. Here, we review the relationship of vitamin D and sunlight to prostate cancer risk. Ultraviolet radiation of the sunlight is the main stimulator for...

  • Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial. Chau, Cindy H.; Price, Douglas K.; Till, Cathee; Goodman, Phyllis J.; Chen, Xiaohong; Leach, Robin J.; Johnson-Pais, Teresa L.; Hsing, Ann W.; Hoque, Ashraful; Tangen, Catherine M.; Chu, Lisa; Parnes, Howard L.; Schenk, Jeannette M.; Reichardt, Juergen K. V.; Thompson, Ian M.; Figg, William D. // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Objective: In the Prostate Cancer Prevention Trial (PCPT), finasteride reduced the risk of prostate cancer by 25%, even though high-grade prostate cancer was more common in the finasteride group. However, it remains to be determined whether finasteride concentrations may affect prostate cancer...

  • Metformin Use Decreases Risk of PCa Diagnosis.  // Renal & Urology News;Jul2014, Vol. 13 Issue 7, p21 

    The article focuses on the study by Mark A. Preston and colleagues which shows the effectiveness of metformin in decreasing the risk of a prostate cancer (PCa) diagnosis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics